title: Comment about the article by Bisson-Vaivre et al.: "The role of HLA and KIR in anti-TNF therapy".
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Grimaldi
authors.forename: Maria Lourdes
authors.initials: ML
authors.lastname: Montesano
authors.forename: Teresa
authors.initials: T
authors.lastname: Infante
authors.forename: Claudio
authors.initials: C
authors.lastname: Napoli
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D011859:Radiography; D025241:Spondylarthritis / Q000000981:diagnostic imaging* / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha